Pharma Journalist - Page 36 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

AbbVie Licenses RemeGen’s RC148 in Major Oncology Partnership

AbbVie to Acquire West’s Arizona Device Manufacturing Facility

FDA Approves ZYCUBO as First Treatment for Rare Menkes Disease

BD Invests $110 Million to Expand U.S. Prefillable Syringe Manufacturing

Solid Biosciences Advances Gene Therapy for Friedreich’s Ataxia

Synaffix and Sidewinder Partner to Develop Next-Generation Bispecific ADCs

FDA Grants Fast Track to Alessa’s Localized Prostate Cancer Therapy

FDA Grants Orphan Status to Cellenkos’ CK0804 in Myelofibrosis

Santhera Licenses AGAMREE to Nxera in Key Asia-Pacific Markets

Lilly Trial Shows Dual Therapy Benefits in Psoriatic Arthritis Patients